Expression of human herpesvirus 8 (HHV-8)-encoded immediate early protein, open reading frame 50, in HHV-8-associated diseases

Journal of Human Virology

Volumn 4, Issue 2, 2001, Pages 96-102

  Katano, H ^a   Sato, Y ^a   Itoh, H ^a   Sata, T ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

HHV 8; Immediate early protein; Kaposi's sarcoma; Multicentric Castleman's disease; ORF50; Primary effusion lymphoma

Indexed keywords

IMMEDIATE EARLY PROTEIN; PHORBOL ESTER; POLYCLONAL ANTIBODY; TRANSACTIVATOR PROTEIN;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; LYMPHOMA; LYMPHOMA CELL; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

CELL LINE; CULTURE TECHNIQUES; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; SARCOMA, KAPOSI; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8; ORYCTOLAGUS CUNICULUS;

EID: 0034971641     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
2. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
3. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease
4. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma
5. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma
6. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection
7. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression
8. Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8
9. High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma
10. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma
11. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease
12. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
13. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
14. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)
15. Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus
16. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus
17. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells
18. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF50 transactivator, a homolog of the EBV R protein
19. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
20. Establishing and characterizing a CD30-positive cell line harboring HHV-8 from primary effusion lymphoma
21. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
22. Clinical manifestations and histopathologic features of classic, endemic African, and epidemic AIDS-associated Kaposi's sarcoma
23. Human herpesvirus 8-associated solid lymphomas that occur in AIDS patients take anaplastic large cell morphology
24. Nuclear domain 10, the site of DNA virus transcription and replication
25. HSV-1 IE protein Vmw110 causes redistribution of PML
26. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells
27. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies